At this moment pharma industry is gearing up to immunize at least 70% of the global population against Covid-19. The center of gravity is gradually shifting from vaccine development to worldwide distribution of the vaccines and the associated cold chain logistic challenges. The supply chain process for this gigantic task is complex, requiring properly functioning storage/packaging, cold chain transit, shipping and storage solutions. As experts estimate that somewhere between 12 billion and 15 billion COVID-19 vaccines need to be distributed globally, the need for a trusted, secure cold chain is very large.
There are several questions the pharmaceutical industry needs to ask itself when it comes to distributing a COVID-19 vaccine, including: